A detailed history of Wade G W & Inc transactions in Novo Nordisk A S stock. As of the latest transaction made, Wade G W & Inc holds 8,845 shares of NVO stock, worth $772,787. This represents 0.03% of its overall portfolio holdings.

Number of Shares
8,845
Previous 4,802 84.19%
Holding current value
$772,787
Previous $437,000 109.38%
% of portfolio
0.03%
Previous 0.02%

Shares

5 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q4 2023

Feb 08, 2024

BUY
$87.78 - $105.45 $354,894 - $426,334
4,043 Added 84.19%
8,845 $915,000
Q3 2023

Nov 08, 2023

BUY
$90.94 - $199.54 $263,453 - $578,067
2,897 Added 152.07%
4,802 $437,000
Q2 2023

Aug 10, 2023

SELL
$155.98 - $172.65 $18,405 - $20,372
-118 Reduced 5.83%
1,905 $308,000
Q1 2023

May 09, 2023

BUY
$132.34 - $159.14 $29,114 - $35,010
220 Added 12.2%
2,023 $322,000
Q4 2022

Feb 10, 2023

BUY
$102.55 - $135.33 $184,897 - $243,999
1,803 New
1,803 $244,000

Others Institutions Holding NVO

About NOVO NORDISK A S


  • Ticker NVO
  • Exchange OTC
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 2,257,289,984
  • Market Cap $197B
  • Description
  • Novo Nordisk A/S, a healthcare company, engages in the research, development, manufacture, and marketing of pharmaceutical products worldwide. It operates in two segments, Diabetes and Obesity care, and Biopharm. The Diabetes and Obesity care segment provides products in the areas of insulins, GLP-1 and related delivery systems, oral antidiabeti...
More about NVO
Track This Portfolio

Track Wade G W & Inc Portfolio

Follow Wade G W & Inc and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Wade G W & Inc, based on Form 13F filings with the SEC.

News

Stay updated on Wade G W & Inc with notifications on news.